AVITA Medical revises 2024 revenue guidance to $64.3 million, citing year-end inventory adjustments, and forecasts 2025 revenue growth of 55%-65% with new product launches.

While not a mind-blowing move, it is good to see that the AVITA Medical, Inc. (NASDAQ:RCEL) share price has gained 15% in the last three months. But that doesn't change the fact that the returns ...

AVITA Medical, Inc. (NASDAQ:RCEL) shareholders are probably feeling a little disappointed, since its shares fell 2.2% to US$17.10 in the week after its latest annual results.

AVITA Medical's Q4 2024 call highlighted its evolution into a multiproduct company with a $3.5B TAM. Key drivers include the April 2025 launch of Cohealyx, RECELL GO Mini's rollout, and ...

Kinderhook’s Avita seeks to become nation’s largest covered entity pharmacy services provider Since Kinderhook's initial platform investment in late 2019, the pharmacy management business has ...

The outdoor sensory playscape at Avita Pediatric Therapy Center will allow children to engage in therapy activities disguised as play.

Shopping for healthcare options? Avita hope local residents will stop by the mall, where new hospital opens in 2017 ...

WESTBROOK – Avita of Stroudwater, Westbrook’s new state-of-the-art, residential assisted-living facility focused on memory care, held its official ribbon-cutting ceremony Nov. 21 at 320 Spring ...

Avita, the leading national HIV-focused pharmacy services organization, announced the completion of its merger uniting four pharmacy companies.

Avita, the leading HIV-focused pharmacy services organization in the nation, today announced the appointment of two new members to its Board of Direct ...